Mellish Island Super Skin Recall Issued for Undeclared Fish Source
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Mellish Island Corp is recalling 1,600 bottles of Mellish Island Super Skin dietary supplement because the label does not declare fish as the source of marine collagen.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 13, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Dietary Supplement.
What Happened Mellish Island Corp initiated a voluntary recall after the finished product label failed to declare the source of marine collagen, which was determined to be fish.
Which Products Are Affected Mellish Island Super Skin; Dietary Supplement; 60 Capsules, 2 per day. UPC: 8 58792 00332 3. Lot: CA1G24. Expiration: 08-2027. 1,600 bottles distributed exclusively through TikTok, presumably nationwide.
What You Should Do Consumers should verify the lot number on purchased bottles. No further consumer instructions are provided in the recall notice.
Why This Matters The Class II recall involves a labeling omission for a potential allergen in a product sold nationwide.
Source FDA recall number H-1190-2026, initiated July 1, 2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (764 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 13, 2026.
Frequently Asked Questions
Common questions about this FDA recall.